Direkt zum Inhalt
Merck

An enzymatic route to selenazolines.

Chembiochem : a European journal of chemical biology (2013-03-14)
Jesko Koehnke, Falk Morawitz, Andrew F Bent, Wael E Houssen, Sally L Shirran, Matthew A Fuszard, Iain A Smellie, Catherine H Botting, Margaret C M Smith, Marcel Jaspars, James H Naismith
ZUSAMMENFASSUNG

Ringing the changes: Selenazolines have applications in medicinal chemistry, but their synthesis is challenging. We report a new convenient and less toxic route to these heterocycles that starts from commercially available selenocysteine. The new route depends on a heterocyclase enzyme that creates oxazolines and thiazolines from serines/threonines and cysteines.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Jodacetamid, BioUltra
Sigma-Aldrich
Jodacetamid, Single use vial of 56 mg
Sigma-Aldrich
Jodacetamid, ≥99% (NMR), crystalline
Sigma-Aldrich
L-Threonin, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 99.0-101.0%
Sigma-Aldrich
L-Threonin, reagent grade, ≥98% (HPLC)
SAFC
L-Threonin
Sigma-Aldrich
L-Threonin, BioXtra, ≥99.5% (NT)
Supelco
L-Threonin, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
L-Threonin, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland